Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus amylovorus and Improved Intestinal Barrier Function

Research synthesisLow evidenceModerate effect3 studies · 3 beneficial · 0 neutral · 0 harmful

Across 3 studies, all reported beneficial moderate-sized effects of Lactobacillus amylovorus on intestinal barrier function, with 2 reaching statistical significance. The evidence is based primarily on animal models (piglets, sows, lambs), limiting direct applicability to humans.

  • Studied populations: Newborn mice/piglets, pregnant sows, weaned lambs

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). All studies were conducted in animal populations (piglets, sows, lambs) rather than humans, so relevance to human intestinal barrier function is uncertain.

Generated May 12, 2026
5 of 5 papers
Back to top